Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Systemic intravenous (IV) as well as local administration of manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) displays no detectable toxicity while offering protection from irradiation-induced damage
New Benefit 360 and Direct Fund models aim to bridge the gap between clinical eligibility and employer-sponsored coverage
Wyatt, A
Chernogubow, A
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
You're training
US$ 26.74
US$ 26.86
US$ 23.09
US$ 29.14
US$ 25.09
US$ 23.00
US$ 21.73
